Post My Press Release

Free Press Release Distribution

Author: Sumaiya234 (Page 1 of 47)

Hospital Beds Market Share, Global Insights and Gross Margin Analysis 2019-2023

The Report of Global Hospital Beds Market by Market Research Future Covers the Information like Denture Adhesive Market Growth, Prominent players, Mega Trends, chapter-wise Description followed by various user perceptions.

Hospital Beds are specially designed for hospitalized patients who are in need of some form of health care services. Different types of hospital beds are available in the market such as advanced electric and semi electric beds.Increasing prevalence of diseases, rising geriatric population, and increasing number of hospitals & clinics drive the     growth of the market. According to the WHO, the number of people aged over 65 was approximately 524 million in 2010, which will reach 1.5 billion by 2050. Furthermore, increasing healthcare spending have fuelled the market growth. However, high cost of the advanced hospitals beds such as electric and semi-electric beds may slow the growth of the market during the forecasted period.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/898

The global hospital beds market is growing at a stable pace and is expected to reach USD 4,824.2 million by 2023 from USD 2,515.1 million in 2016 at a CAGR of 5.5% during the forecasted period 2017-2023.

Key Players:

Some of the key players in the global market: Hill-Rom Holdings, Stryker Corporation, Linet spol. s r.o., Invacare Corporation, Paramount Bed Holdings Co., Ltd., Gendron Inc., and Getinge AB.       

Hill-Rom Holdings, headquartered in Batesville, Indiana, the US, is one of the leading global medical technology company. In 2017, the company announced the launch of the new Hill-Rom 900 Accella bed system for higher acuity patients in intensive and acute care settings.

Segmentations:                                                                                                                      

The global hospital beds market is majorly segmented on the basis of type, power, end users, and regions.

On the basis of types, the global hospital beds market is segmented into acute care, long-term care, psychiatric & bariatric care, and others (maternity and rehabilitation beds).

Based on the power, the market is segmented into electric bed, semi-electric bed, and manual bed.

Based on end users, the global hospital beds market is segmented into hospital, clinics, ambulatory, and others.

Taste the market data and market information presented through more than 140 market data tables and figures spread over 118 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “hospital beds market research report–Global forecast till 2023.”

Regional Analysis:

The global hospital beds market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

Europe holes the largest share of the global hospital beds market due to increasing government support and high healthcare spending. Moreover, continuous technological development and the growing presence of the global market leaders contribute to the market growth. The Americas is the second largest market due to strong economic conditions, huge geriatric population, and well-developed healthcare sector. Moreover, improving reimbursement policies is expected to fuel the growth of this market.

Asia Pacific is the fastest growing market due increasing prevalence of chronic diseases, growing government encouragement in healthcare sector, and increasing geriatric population will boost the market growth over the forecasted period. Additionally, increasing number of hospitals, increasing number of life-threatening diseases, and increasing healthcare expenditure have fueled the growth of the market.

However, the Middle East & Africa holds the least share in the market due to limited access to the healthcare resources and lack of technological development in healthcare facilities.

Browse Complete 148 Pages Premium Research Report Enabled with 131 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/hospital-bed-market-898

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Empty Capsule Market 2019 Business Insights & Deep Analysis to 2023 by World’s Top 10 Key Players

MarketResearchFuture.com (MRFR) in it’s Recently Announced study report asserts that the “Global Empty Capsule Market” the report offer detailed insights about the Historical Trends and Current Scenario with Top Industry Players, Demand, Major Drivers and Industry Dynamics up to 2023.

An empty capsule is an oral dosage which resting on the manufacturing material type is available in assorted colors and sizes such as flavored capsules and pearl capsules. Capsules are available in different types such as rectal capsules, enteric coated capsules, sustained release capsules, hard gelatin capsules and soft gelatin capsules. Hard and soft capsules are the commonly used empty capsules. An empty capsule comes in assorted sizes that helps in customization and dose calibration as per the needs of the individual.

Capsules are highly favored as it is easy to swallow, have an odorless and tasteless gelatin coating that makes it palatable, causes decreased gastrointestinal irritation and have quicker dissolution times compared to other forms of oral dosage.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7153

The Global Empty Capsule Market is predicted to have a promising growth at a striking 8.8% CAGR over the forecast period (2018-2023). Capsules provide a viable substitute to tablets especially for its wide availability and easy administration. A capsule is a stable shell which is utilized to encapsulate active ingredients that are formulations possessing therapeutic activity. It is widely used in pharmaceutical industries especially when it is difficult to compress a drug in a solid tablet.

There are many factors that is driving the growth of the empty capsule market. Some of these factors as per the Market Research Future (MRFR) report include increasing use of capsule formulations amid the geriatric population, rising research and development activities and clinical trials, advancements in the capsule delivery technology, growth of pharmaceutical market, easy digestibility, easy to consume, ease of availability, rising consumer preference for capsules over tablets and surge for nutraceutical products. On the contrary, factors such as constricted regulatory guidelines laid down by the international and national regulatory authorities, lack of advanced medicinal facilities especially in under-developed nations, high initial investment, scarcity of skilled healthcare experts, prerequisite R&D, increasing raw material prices, religious and cultural issues associated to capsule consumption having animal-derived ingredients such as bovine and porcine gelatin capsule shells may hinder the growth of the empty capsule market.

Top Players:

  • Arab Caps
  • Sunil Healthcare Limited
  • NecLife
  • ACDIMA
  • Capsugel
  • Medi-Caps Ltd
  • ACG-Associated Capsules and others.

Regional Analysis:

Based on region, the empty capsule market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and the Middle East and Africa. Of these, North America is anticipated to grab the largest share in the market due to high healthcare expenditure, well-developed technology and huge patient population. The empty capsule market in Asia Pacific will have the second biggest share followed by Europe. The market in the APAC region is the fastest growing due to the quickly changing healthcare sector. On the other hand, the empty capsule market in the Middle East and Africa will have minimum share due to the existence of slow and poor developing countries particularly in the African region. The market in the Middle East will have a major share owing to high spending and well-developed infrastructure.

Segmentation:

Market Research Future report offers an all-inclusive segmental analysis of the Empty Capsule Market on the basis of raw materials, physical characteristics, certification and end user.

Based on raw materials, it is segmented into non-gelatin, porcine and bovine.

Based on physical characteristics, the empty capsule market is segmented into soft and hard capsules. Of these, soft capsules will have the largest market share over the forecast period.

Based on certification, it is segmented into non-halal certification, halal certification and others. Of these, halal certification will lead the empty capsule market.

Based on end-user, the empty capsule market is segmented into academic and research organizations, pharmaceutical industries and others. Of these, the pharmaceutical industries are anticipated to have the largest share in the market.

Browse Full Report at https://www.marketresearchfuture.com/reports/empty-capsule-market-7153

TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

Continued…!

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

2019 Latest Study explores the Custom Antibody Market Witness Highest Growth in near future by 2023

Global Custom Antibody Market Analytical Surveying Report is added on Marketresearchfuture.com with 85 pages. Global Custom Antibody Market is projected to reach 9.6% CAGR value up to 2023.

Global Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period (2018–2023). The increasing demand of custom monoclonal/ custom polyclonal antibodies is due to their numerous advantages such as batch-to-batch reproducibility, rapid production along with their capability of data reproducibility within research is propelling the growth of the custom antibody market.

The Americas is projected to lead the custom antibody market in the forecast period. Using commercially available antibodies can hinder the production level of high-quality antibodies which are used to treat immune system related diseases and others.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7062

Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market. Also, growing investments in the progress of structure-based drug designs, growing focus on developing antibody-based therapeutics, rising research in the fields of genomics field, increasing demand for good quality research tools for data reproducibility and the existence of a huge number of global players in this region.

Key Players

Some of the key players in the global custom antibody market are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.

Segmentation:

The global custom antibody market has been segmented on the basis of service, source, type, research area and end users.

On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen preparation, immunization & hybridoma production. On the basis of source, the market has been classified as mice, rabbits, human beings and others. On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others. On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas. On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.

Browse Complete 85 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/custom-antibody-market-7062

Some Points from TOC of Custom Antibody Market Research Report – Global Forecast till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

TOC CONTINUED…!

Check Discount at https://www.marketresearchfuture.com/check-discount/7062

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Companion Diagnostics Market 2019 Size, Business Research, Revenue, Growth Insights to 2023

Market Research Future (MRFR) recently published a brilliant study report giving out the complete market insights up till 2022. In its report MRFR asserts that the global Companion Diagnostics market is projected to grow exponentially by 2022, registering a phenomenal CAGR throughout the forecast period (2016 – 2022). Burgeoning healthcare sector is a key factor propelling the market growth.

Companion Diagnostic a therapeutic device, is used to diagnosis a treatment response in the patients as frequently as an in vitro gadget. The device provides information that is essential for the safe and effective use of a corresponding drug or biological product. The outcome (diagnostic report) helps a health care professional to determine is the benefits of a particular therapeutic product will compensate with some potential serious side effects or risks.

Similarly, Companion Diagnostics are also used in drug development process by determining Companion biomarker that help predict likely response of toxicity. Lung Cancer, Colorectal Cancer, Breast Cancer, Melanoma Cancer, Gastric Cancer, Genital Cancer, and deadly infectious disease like HIV are some of the various types of biomarkers available in market.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1622

Over the past few years, Companion Diagnostics has evolved greatly with the advancements in biotechnology.  Moreover, owing to the growing prevalence of chronic diseases such as cancer & HIV, Companion Diagnostics has garnered an exclusive prominence. This has resultantly escalated Companion Diagnostics market on the global platform.

In addition other factors contributing to foster the market growth include; growing population, urbanization coupled with the adoption of heady, inappropriate lifestyle that fuels the instances of chronic diseases. Continuous advancement in medical technology both for the diagnosis and the treatment of patients also drive the market growth pervasively. Also, awareness among physician and patient about the drug toxicity is providing impetus to the market growth.

On the other hand, scepticism of physicians towards the advancement & efficacies of these devices is likely to restrict the market growth.

In developing countries due to less awareness, Companion Diagnostics is not as much in practice as in developed countries but the developing countries with huge population like India & China have a huge potential to pool in the market share.

Whereas in developed countries, lack of skilled professionals and lack of awareness is hampering the growth of Companion Diagnostics Market. Besides, logistic issues raised so as to develop companion diagnostics and drug together is posing challenges to the market growth.

Top Players:

Qiagen (Germany), Dako (Denmark), f. Hoffmann-la Roche ltd (Switzerland), Ventana Medical Systems, Inc. (US), Abbott Laboratories, Inc. (US), Resonance Health (Australia) and Agilent Technologies (US) are some of the leaders driving the Global Companion Diagnostics Market. Profiling those in its analysis MRFR finds out their strategies placing them at the forefront of completion.

Worldwide Companion Diagnostics Market – Competitive Landscape

The market of Companion Diagnostics appears to be fiercely competitive & fragmented owing to the presence of numerous matured & small key players accounting for a substantial market share. These market players try to gain competitive advantage through strategic partnership, acquisition, expansion, collaboration, product & technology launch. They invest heavily in the R&D to develop a technology that is completely on a different level compared to their competition. 

Industry/Innovation/Related News:

January 30, 2018 – One Million Solutions in Health (UK), a global community working to stimulate ideas, innovation and solutions announced it has received license for its ground-breaking innovation – basically a biomarker that can also be used as a companion diagnostic to aid in clinical decision-making related to cancer treatments.

January 29, 2018 – Meso Scale Diagnostics, LLC. (US), a leading global maker & marketer of products & services for biological detection, announced that it has received its first clearance from the FDA for an in vitro diagnostic.

Ask Any Questions at https://www.marketresearchfuture.com/enquiry/1622

Sep. 2017 – Thermo Fisher Scientific (US) a leading global provider of biotechnology product development announced partnership with the Institute of Pathology Heidelberg (IPH). The initiative focuses on forging strategic collaborations with leading, European-based organizations that can lead studies using Thermo Fisher’s Oncoming portfolio of research panels destined for development as Companion Diagnostics to help drive precision oncology in the region.

Worldwide Companion Diagnostics Market – Segmentations

For the convenience of the report and enhanced understanding; the report is segmented in to 4 key dynamics

By TypesComprises Monitoring Tests, Theranostics Tests among others.  

By End UsersResearch Laboratories, Hospital, Medical Institutes and others.

By ApplicationsCardiovascular, Cancer Diseases, Central Nervous Systems and others.

By Regions:  Europe, North America, APAC and Rest of the World.

Worldwide Companion Diagnostics Market – Geographical Analysis

North America market dominates the global Companion Diagnostics market with the significant market share. The market is further expected to reach astronomical amounts growing at a substantial CAGR throughout the forecast period (2016-2022).

Europe & Asia Pacific is the second & third largest market respectively in the global Companion Diagnostics market. Expected to be a fastest growing market Asia pacific region is estimated to grow rapidly over the projected period.

Check Discount at https://www.marketresearchfuture.com/check-discount/1622

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Integrated Operating Room Management Systems Market 2019: Size, Upcoming Trends, On-Going Demand, Growth and Forecast from 2019 to 2023 with Most Prominent Key Players

The Recent Study Conducted by Market Research Future (MRFR), the Global Integrated Operating Room Management Systems Market will capture an impressive growth rate during the review period 2019-2023.

Advancement of medical technology has resulted in the rapid development of advanced diagnostic, and therapeutic technology, thus making operating rooms more complex and increasingly congested. As such, integration has been deemed necessary for maintaining efficiency in operating rooms. Integrated operating room systems offer simplification and streamlining of several operating room tasks. The increasing prevalence of various diseases and medical conditions due to the growth of the global population as well as changing lifestyles has led to a significant increase in the number of surgeries being performed across the globe, thus driving market growth.

Rapid expansion of the global healthcare sector has resulted in increased efficiency of several medical processes. Operating room integration systems offers consolidation of large volumes of data and allows control from a central command station, thus increasing efficiency in the operating room. Market Research Future’s detailed analysis of the global integrated operating room management systems market has led to several key findings which offer conclusive information regarding the growth of the market over the forecast period from 2018 to 2023. In 2017, at the start of the forecast period, the integrated operating room management systems market was valued at USD 766.88 Mn and is projected to expand at an optimistic CAGR of 10% during the review period. Following this trajectory, the integrated operating room management systems market is likely to reach a market value of USD 1,521.81 by 2023.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6906

Additionally, insurance reimbursements for surgeries have been improving considerably. For instance, according to the Surgical Neurology Internation, Medicare reimbursed USD 142,075 for neurosurgeries and a similar amount for orthopedic surgeries. As a result, more patients are choosing otherwise unaffordable surgical treatments, thus increasing demand for efficient surgical operations and procedural management.

Notably, risk factors associated with surgeries make patients hesitant to receive surgical operations, and despite favorable reimbursement policies, hospitalization comes with a hefty bill which further discourages patients and restrains market growth. However, with medical tourism growing at a rapid rate, patients are likely to go to regions like the Asia Pacific for treatment, thus creating opportunities for growth in the foreseeable future.

Top Players:

Market Research Future has included a detailed review leading market players’ growth strategies. Prominent market participants that have been reviewed in the report include KARL STORZ GmbH & Co. KG, Cook Medical, Steris plc, Johnson & Johnson Services Inc, Canon Inc., GE Healthcare, Olympus Corporation of the Americas (Image Stream Medical Inc.), Koninklijke Philips N.V., Danaher Corporation (Leica Microsystems GmbH), Stryker Corporation, Skytron LLC, and Barco.

Segmentation:

The integrated operating room management systems market which is composed of various components has been segmented, in MRFR’s report on the basis of device, surgical application, type, and region. Devices in integrated operating room systems have been segmented into operating tables, operating room lights, operating room communication systems, intraoperative diagnostic devices, and others. The operating tables segment has captured the largest share of the market and is expected to proliferate at a CAGR of 10.3% during the assessment period. Growing at a marginally faster rate is the intraoperative diagnostic devices segment.

Surgical applications of integrated operating room systems have been segmented primarily into therapeutics and diagnostics imaging. Further sub-segmentations have been mentioned in the report. Rising incidences of cardiovascular diseases have propelled the therapeutics segment into a leadership position. This segment is also anticipated to grow at the fastest pace over the forecast period.

Types of integrated operating room systems have been segmented to include recording & documentation system, operating room & procedure scheduling system, anesthesia information management, audio & video management system, instrument tracking system, and operating room inventory management system. Increasingly enhanced processes of patient care and quality assurance has given the Anesthesia Information Management Systems an advantage over other segments in terms of market size. Valued at USD 173.02 Mn in 2017, the integrated operating room management systems market is on track to reach USD 351.65 Mn by the end of 2023.

Regional Analysis:

Division of the global integrated operating room management systems market segments the integrated operating room systems market into the Americas, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the Americas captured the most significant share of the market and the regions projected growth is likely to keep it in a leadership position over the forecast period. The region’s large piece of the market can be explained by the observed increase in preference for surgical and minimally invasive procedures. The region has developed economies such as Canad and the U.S where the healthcare sector is well developed and displays an affinity for the early adoption of advanced medical technologies. Increasing applications of integrated operating rooms drive the market.

Meanwhile, the Asia Pacific is slated to grow at the highest CAGR of 12.3% during the review period. The region is experiencing rapid growth of the healthcare sector, and many healthcare reforms are taking place. Several major countries in the region are also experiencing rapid economic development and the immense patient pool in these countries has led to an increased demand for efficiency. Increasingly favorable reimbursements and rapidly growing medical tourism have resulted in increased adoption of integrated operating room systems. The region represents significant promise for the future of the market.

Browse Complete 160 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/integrated-operating-room-management-systems-market-6906

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Dural Arteriovenous Fistulae Treatment Market 2019 Global Dynamics, Trends, Opportunities, Drivers, Challenges and Influence Factors Shared in a Latest Report

The Exhaustive Study for Global Dural Arteriovenous Fistulae Treatment Market Research Report is added on Market Research Future. To provide detail analysis of the market structure along with forecast, about various segments and sub-segments of the Dural Arteriovenous Fistulae Treatment

Dural Arteriovenous Fistulae Treatment Market – Highlights

Dural arteriovenous fistula is an abnormal connection between an artery and a vein. Any organ of the body can suffer from fistula. The brain is bounded by a tough fibrous cover called dura mater or dura. When a fistula forms between an artery and a vein within the dura, it is called brain dural fistula.

According to Migraine Research Foundation, migraine was the 3rd most prevalent illness in the world in 2014. The prevalence of migraine is very high in the US, which is nearly 1 in 4 people. Moreover, 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55.

Increasing prevalence of neurological disorder such as epilepsy and migraine leads to dural arteriovenous fistulae, and increasing investment in biotechnology and pharmaceutical industries in R&D drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology projected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth in the same period.

The Global Dural Arteriovenous Fistulae Treatment Market is expected to grow at a CAGR of ~ 7.68 % during the forecast period 2017-2023.

Request Free Sample copy at https://www.marketresearchfuture.com/sample_request/4589

Key Players:

Some of key the players in the market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited.

Segments:

The global dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.

On the basis of type, the market is segmented into type I, type II, and type III.

On the basis of application, the market is segmented into surgery, stereotactic radiosurgery, embolization, and others.

On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others.

Regional Analysis:

The Americas dominates the global dural arteriovenous fistulae treatment market owing to the presence of huge patient population with brain injury and neurological disorder such as depression, epilepsy, and migraine, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global dural arteriovenous fistulae treatment market. The increasing focus of various government agencies on treating epilepsy, depression, and heart attacks expected to have a positive impact on the growth of the market over the assessment period. Additionally, growing public awareness may boost the adoption of these devices in the European market.

Asia Pacific is the fastest growing dural arteriovenous fistulae treatment market across the globe. In this region, Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.  Furthermore, increasing patient population in India estimated to generate various new opportunities for the growth of the market in the given period.

The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East and African market. Whereas, the African region is expected to witness a moderate growth over the forecast period.

Some Points From TOC of Dural Arteriovenous Fistulas Treatment Market Research Report- Global Forecast till 2023

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…

Browse Complete 95 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/dural-arteriovenous-fistulas-treatment-market-4589

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Emergency Department Information System Market 2019 – Investment Strategy, Outlook and Key Development till 2023

Global Emergency Department Information System Market Report include on MarketReseacrhFuture.com with exhaustive Study. The report aims to provide an overview of Global Emergency Department Information System Market Report.

The Global Emergency Department Information System Market can expect a growth rate of 15.10% during the forecast period (2017-2023), says Market Research Future (MRFR).

Market Drivers and Key Restraints

Emergency department information system is consisted to be an essential component in hospitals with emergency departments being a hospital’s front door for residents. Thus, the services offered in the emergency department directly reflect the hospital image. This system automates as well as streamlines the work process, providing the patients with efficient and high-quality care. These are designed with inputs from the medical professionals, along with nurses, healthcare administrators, clinicians, and pharmacists to cater to every need that ensures the smooth operation of the emergency department.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5926

The critical factors shaping the emergency department information system market include the growing number of hospitals and surge in healthcare expenditure. Apart from this, with the rising demand for automated healthcare services, supplemented by the increasing number of diseases, the market is expected to maintain its growth in the future as well.  The expanding patient pool, along with the rising need to maintain an updated patient record as well as upgraded systems in healthcare, would also add to the market’s strength.

Having said that, the lack of knowledge about the system could slow down the market growth in the ensuing years. However, few crucial drivers dictating the smooth trajectory of the worldwide market include the increasing geriatric population and the growing adoption of technologically advanced systems in the healthcare sector.

Market Segmentation

The worldwide market for emergency department information system has been split into the segments of end-user, application, component, and delivery mode.

Component-wise, the market includes hardware, software, and services. In the market, the software segment covers the maximum share of the market and is poised to achieve a CAGR of 15.39% from 2017 to 2023.

With respect to application, the market covers administrative functionalities and clinical functionalities.

In terms of delivery mode, the market comprises on-premise and software-as-a-service (SaaS). Between these, the SaaS segment has seized the biggest portion of the total market, and expects to grow at a CAGR of 15.33% in the subsequent time frame.

The end-users that are part of the market are medium-sized hospitals, large hospitals, and smaller-scale hospitals. Out of these, the large hospitals segment has grabbed the primal spot, acquiring 48% of the total share.

Regional Analysis

The primary markets for emergency department information system include Asia Pacific, Europe, the Middle East & Africa and the Americas.

The Americas region, with close to 38.6% of the total market share to its name, was the top region in 2016. The market will have a sustained growth in the future as well, owing to the presence of a large number of significant manufacturers and technological advancements within the region. Other than this, the high adoption rate of emergency department information systems will auger well with the market growth.

Europe thrives as the second-leading emergency department information system market on account of the rising use of information technology and improved developed healthcare facilities. These factors accelerate the demand for emergency department information system within the region.

The fastest-developing region is that of Asia Pacific, with a projected CAGR of 15.71% in the ensuing years. The region marks unmatched opportunities and consistently growing countries. Herein, improving economies, growing number of public and private hospitals and latest healthcare developments will favor the market growth.

The Middle East & Africa market is projected to experience substandard growth compared to other regions, with predictions of it noting the same growth pattern in the coming years as well. The lack of economic development coupled with low level of disposable income in the region could be the chief reasons for the sluggish growth.

Prominent Companies

The prominent companies in the emergency department information system market include Cerner Corporation, Medhost Inc, Evident, EPOWERdoc, Inc, T-System Inc, Wellsoft, Allscripts, veEDIS Clinical Systems LLC, Unitedhealth Group, Epic Systems, Inc, Logibec Canada, Healthland, Inc, Mckesson Corporation, Siemens Healthcare, Medical Information Technology, Inc, to name a few.

Industry Developments

February 2019

Medsphere has acquired Wellsoft Corporation, a company that specializes in emergency department information system. The acquisition’s primary aim is to launch a solution for urgent care centers, says Medsphere.

Browse Full Report at https://www.marketresearchfuture.com/reports/emergency-department-information-system-market-5926

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

2019 Worldwide Non-sterile compounding pharmacy Market Analysis, Market Share, Application Analysis, Regional Outlook, Competitive Strategies & Forecast by 2023

This MRFR Report offers a Thorough Analysis of the Global non-sterile compounding pharmacyMarket. The Report offers insights into the Leading Market Players and Presents an Assessment of their Current Market Position.

global non-sterile compounding pharmacy market that predicts growth for this market at a 2.65% CAGR (Compound Annual Growth Rate) between 2017 and 2023.

The key factors driving the global non-sterile compounding pharmacy market growth include the growing demand for anti-aging products (especially in Europe and the USA), exposure to harmful radiation, hereditary reasons & genetic mutations (abnormal changes), and increasing geriatric population. Other major factors aiding the market growth include government initiatives favorable to the market, rising per capita income in developed countries (and in some developing countries), the increasing prevalence of chronic diseases, and the rising need for customized medicine. However, high prices, long approval time for clinical trials, and strict regulations governing the manufacturing of the compounded product can hinder the market growth.

Request Sample copy at https://www.marketresearchfuture.com/sample_request/4669

The global non-sterile compounding pharmacy market has been segmented on the basis of application, end user, product, and lastly, region. The application-based segmentation segments this market into hormone replacement therapy and pain medication. Based on the end users, the market has been segmented into compounding pharmacies, hospitals, and others. By product, the market has been segmented into otologic/nasal medication, oral medication, topical medication, and others.

The regional segmentation of the global non-sterile compounding pharmacy market segments the market into North America and Europe.

North America is the biggest regional market because of the presence of the USA, which is large enough to be the largest regional market in the world. The USA is equipped with most advanced medical facilities, high level of research and development (R&D), the increasing prevalence of chronic diseases, rising demand for customized medicine, the presence of key market players, a rising number of hospital-based compounding pharmacies, and a sizable portion of the population suffering from chronic ailments.

Europe is the second largest regional market due to the high density of population, and the availability of advanced medical facilities in most of the European countries. Due to technological advancement, Western Europe is a bigger market than Eastern Europe. In this region, the strongest economies that can become the perfect markets are France, Germany, Italy, the Netherlands, Spain, and the UK, followed by the remaining countries of Western Europe and Eastern Europe. Europe is also the base of many key players in the global non-sterile compounding pharmacy market.

The remaining countries of this world also have markets for non-sterile compounding pharmacy, but they are not considered priority markets.   

Key Players

The key players in the global non-sterile compounding pharmacy market include B.Braun Melsungen AG (Germany), Dougherty’s Pharmacy Inc. (USA), Fagron (the Netherlands), Fresenius Kabi AG (Germany), Pharmedium (USA), and True Nature Holding INC (USA).

Latest Industry News

  • Wellspring has opened a compounding pharmacy in Berkeley, California. 1 NOV 2018
  • Mecart, the Canadian cleanroom builder, has released a virtual reality (VR) tour of a 700 ft2 cleanroom it delivered for a non-sterile compounding pharmacy in Quebec. It is planning to build it for a client. 29 AUG 2018
  • All sterile compounded drug products from Pharma D Solutions were voluntarily recalled and withdrawn due to a potential contamination risk at the pharmacy. 17 SEP 2018
  • La Vita has forged a partnership with the leading integrative medical providers in the USA. This partnership aims to innovate the personalized medications to treat their patient’s needs. 23 AUG 2018
  • The US Food & Drug Administration (USFDA) has urged veterinarians and other animal health care professionals to check their medical supplies and quarantine any “sterile” drug products produced by Jeannette, Pennsylvania-based Ranier’s Compounding Laboratory. 10 JUL 2018

Browse Complete 101 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/non-sterile-compounding-pharmacy-market-4669

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Page 1 of 47

Powered by WordPress & Theme by Anders Norén